Skip to main content
. 2018 Feb 20;110(7):768–776. doi: 10.1093/jnci/djx268

Figure 4.

Figure 4.

Comparison of the expression of various immune cell types between estrogen receptor (ER)–positive/human epidermal growth factor receptor 2 (HER2)–negative invasive lobular carcinoma. Distribution of the expression of the various immune markers assessed by immunohistochemistry in the Nottingham cohort according to the histology and their localization. For each comparison, the value in parentheses refers to the multivariable-adjusted P value from the proportional odds logistic model extension of the Mann-Whitney test according to Harrell (24) with the following covariates: histological subtype, age, grade, axillary lymph node, and Ki67 status. ER = estrogen receptor; ILC = invasive lobular carcinoma.